Moderator: Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
[email protected] | 973-642-8382 or 973-761-9000 ext. 8382
PROGRAM SCHEDULED for October 9, 2026 | In-Person
PROGRAM SCHEDULED for June 11, 2027 | Virtual
All times are in Eastern Standard Time.
8:30 - 9:00
Registration & Breakfast
9:00 - 9:05
Welcome & Format Review
9:05 - 10:05
International Anti-Corruption Enforcement
Moderator: Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
10:05 - 10:20
Break
10:20 - 11:20
Compliance-Specific Takeaways in Terms of Enforcement Priorities
Gary Giampetruzzi
Partner, Litigation Department, Paul Hastings LLP
Garrett Schuman
Senior Counsel, Johnson & Johnson
Terra Buckley
Chief Compliance & Ethics Officer, Bristol Myers Squibb
Patrick Gibson
Lead Compliance Counsel, Investigations, and Operations, Otsuka
11:25 - 12:25
Third Party Arrangements
Matthew Sullivan
Partner, Disputes, Hogan Lovells Cadwalader
12:25 - 1:15
Lunch Break
1:15 - 2:15
Case Study: Leading Positive Change Under a Deferred Prosecution Agreement Monitorship
Gregory Paw
Partner, Freeh, Sporkin & Sullivan
Christine Gordon
Chief Compliance Officer, Olympus Corporation of the Americas
David Walk
Deputy Chief, Criminal Division, U.S. Attorney’s Office, District of New Jersey
2:20 - 3:45
Practical Application Case Study
Wendy Tsuei
Founder, ComplianSure
3:45
Program Close
